Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Prokidney (PROK) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to $294.3 million.

  • Prokidney's Shares Outstanding (Weighted Average) rose 1.59% to $294.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $294.3 million, marking a year-over-year increase of 1.59%. This contributed to the annual value of $291.7 million for FY2024, which is 23.88% up from last year.
  • Latest data reveals that Prokidney reported Shares Outstanding (Weighted Average) of $294.3 million as of Q3 2025, which was up 0.54% from $292.7 million recorded in Q2 2025.
  • Over the past 5 years, Prokidney's Shares Outstanding (Weighted Average) peaked at $294.3 million during Q3 2025, and registered a low of $31.9 million during Q1 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $235.4 million (2023), whereas its average is $260.3 million.
  • As far as peak fluctuations go, Prokidney's Shares Outstanding (Weighted Average) soared by 636.66% in 2023, and later dropped by 2.37% in 2024.
  • Over the past 4 years, Prokidney's Shares Outstanding (Weighted Average) (Quarterly) stood at $232.8 million in 2022, then climbed by 1.15% to $235.4 million in 2023, then grew by 23.88% to $291.7 million in 2024, then increased by 1.59% to $294.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $294.3 million in Q3 2025, compared to $292.7 million in Q2 2025 and $292.7 million in Q1 2025.